For our Minds Behind Organ-on-Chip series we had the opportunity to speak to Valentin Wegner from the University Hospital Jena in Germany. He works on the modulation of CAR T-cell efficacy by short-chain fatty acids in a ROR1-positive intestinal adenocarcinoma-on-chip model.